Lowest Price Guaranteed From USD 4,799
The flow cytometry market (services) is estimated to be worth $2.76 billion in 2022 and is expected to grow at compounded annual growth rate (CAGR) of 9.73% during the forecast period. First introduced in 1950s, the flow cytometry technique has gained significant attention in the past few decades. This can be attributed to the fact that flow cytometry has been demonstrated to be capable of overcoming various challenges associated with conventional analytical techniques, such as western blotting and immunohistochemistry. The key concerns related to traditional approaches include low specificity and sensitivity, time and cost intensive procedures, higher chances of producing false results. Specifically, flow cytometry analysis offers several advantages over the conventional methods intended for single cell flow cytometry analysis. For instance, using microscopy, about 6 parameters of a single cell can be detected, whereas flow cytometer instruments enable the detection of up to 30 distinct parameters. In addition, the modern flow cytometer is capable of processing over 10,000 cells per second, thereby, enabling scientists to rapidly analyze and characterize millions of cells. Currently, flow cytometry analysis is used in a number of applications in the medical industry, including assisting in evaluation of autoimmune disorders and infectious diseases, and diagnosis of leukemia and lymphoma. The increasing prevalence of chronic conditions has led to a rise in the number of focused research efforts being carried out; this has further created a considerable demand for advanced and rapid analytical techniques to better understand the disease morphology. In this context, the adoption of flow cytometry technique has witnessed considerable growth. However, this approach often requires the use of complex and expensive flow cytometry instruments, which need to be operated by highly trained professionals. Several small and mid-sized players usually do not have the resources to make such exorbitant investments. Therefore, outsourcing has emerged as a preferred operational model for flow cytometry innovators, who rely on specialty contract service providers / flow cytometry companies to handle various aspects of flow cytometry services.
At present, 30 players claim to offer a range of flow cytometry services, including customized assay development services, manufacturing of consumables (such as dyes and buffers) used for flow cytometry analysis, flow cytometry analysis of various immune cells for various clinical and non-clinical studies, and cell line development. Further, 25 flow cytometry companies are currently engaged in the manufacturing of novel and advanced flow cytometers. To keep pace with the increasing demand for such services, players are not only actively undertaking initiatives to improve / expand their existing offerings but also entering into strategic partnerships with several industry stakeholders to broaden their respective services portfolios. For instance, in April 2021, Agilex Biolabs acquired TetraQ in order to further broaden its portfolio for analytical services offered via flow cytometry. Driven by the increasing number of clinical studies focused on evaluating treatment modalities against chronic disorders, we believe that the flow cytometry market is likely to witness a steady market growth during the forecast period.
Examples of key flow cytometry companies providing services in flow cytometry market (which have also been profiled in this market report; the complete list of flow cytometry companies is available in the full report) include FlowMetric Life Sciences, Flow Contract Sites Laboratory, Bio-Legend, Q2 Solutions, ProImmune, MLM Medical Labs, Unilabs, Firalis and Agilex Biolabs. This market report includes an easily searchable excel database of all the flow cytometry companies providing flow cytometry service, worldwide.
Several recent developments have taken place in the field of flow cytometry market. We have outlined some of these recent initiatives below. These developments, even if they took place post the release of our market report, substantiate the overall market trends that have been outlined in our analysis.
The “Flow Cytometry Market by Type of General Flow Cytometric Services (Assay Development and Consumables Manufacturing), Type of Analysis based Flow Cytometric Services (PBMC Analysis, Whole Blood Cells Analysis, Bone Marrow Aspirate Analysis, Stem Cells Analysis, Rare Cells Detection, Cell Profiling and Subsetting and Intracellular Staining), Other types of Flow Cytometric Services, Type of Accreditations (Government and Third-Party Accreditations), Key Players, and Key Geographical Regions (North America, Europe, Asia Pacific and Rest of the World): Industry Trends and Global Forecasts, 2022-2035”, market report features an extensive study on the current market landscape, market size, market forecast and future opportunities for the flow cytometry service providers market during the forecast period.
The market report includes an in-depth analysis, highlighting the capabilities of various industry stakeholders engaged in flow cytometry market.
In addition to other elements, the market research report includes:
One of the key objectives of this market report is to provide a detailed market forecast analysis in order to estimate the existing market size and future opportunity associated with the flow cytometry market during the forecast period. We have provided an informed estimate of the evolution of the market for the forecast period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented on the basis of region (North America, Europe and Asia-Pacific). In order to account for the uncertainties and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.
The opinions and insights presented in the market research report are backed by a deep understanding of key insights generated from our secondary research.
All actual figures have been sourced and analyzed from publicly available information forums. Financial figures mentioned in this market report are in USD, unless otherwise specified.